DCF — FRYE REGIONAL MEDICAL CENTER
Enterprise Value: $-239.6M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-239.6M
Enterprise Value
$-79.8M
PV of Cash Flows
$-159.8M
PV of Terminal Value
$-257.4M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $268.7M | $-12.7M | -5.0% | $-24.1M | $-21.9M |
| Year 2 | $276.8M | $-10.4M | -4.0% | $-22.1M | $-18.2M |
| Year 3 | $285.1M | $-7.8M | -3.0% | $-19.9M | $-14.9M |
| Year 4 | $293.6M | $-6.6M | -2.0% | $-19.0M | $-13.0M |
| Year 5 | $302.4M | $-6.0M | -2.0% | $-18.8M | $-11.7M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-239.6M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$260.9M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.052451434622792906
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5